Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a vaccine stop oral HPV in men with HIV?

NCT ID NCT04255849

First seen Feb 01, 2026 · Last updated Jun 09, 2026 · Updated 11 times

Summary

This study tests whether the nine-valent HPV vaccine can prevent long-lasting oral HPV infections in men who have HIV. About 700 men will receive either the vaccine or a placebo. The goal is to see if the vaccine reduces new persistent infections with HPV types linked to throat cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV -1 INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Instituto Nacional de Salud Pública, Mexico

    Cuernavaca, Morelos, 62209, Mexico

  • Universidade de São Paulo

    São Paulo, São Paulo, 05403-911, Brazil

  • University of Puerto Rico AIDS Clinical Trials Unit

    San Juan, Purto Rico, 00935, Puerto Rico

Conditions

The condition(s) this trial relates to.

HIV infectious disease human papilloma virus infection oropharynx squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.